Cargando…
Stability Study of mRNA-Lipid Nanoparticles Exposed to Various Conditions Based on the Evaluation between Physicochemical Properties and Their Relation with Protein Expression Ability
Lipid nanoparticles (LNPs) are currently in the spotlight as delivery systems for mRNA therapeutics and have been used in the Pfizer/BioNTech and Moderna COVID-19 vaccines. mRNA-LNP formulations have been indicated to require strict control, including maintenance at fairly low temperatures during th...
Autores principales: | Kamiya, Mariko, Matsumoto, Makoto, Yamashita, Kazuma, Izumi, Tatsunori, Kawaguchi, Maho, Mizukami, Shusaku, Tsurumaru, Masako, Mukai, Hidefumi, Kawakami, Shigeru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697436/ https://www.ncbi.nlm.nih.gov/pubmed/36365175 http://dx.doi.org/10.3390/pharmaceutics14112357 |
Ejemplares similares
-
Effect of Cholesterol Content of Lipid Composition in mRNA-LNPs on the Protein Expression in the Injected Site and Liver After Local Administration in Mice
por: Kawaguchi, Maho, et al.
Publicado: (2023) -
Induction of liver-resident memory T cells and protection at liver-stage malaria by mRNA-containing lipid nanoparticles
por: Nakamae, Sayuri, et al.
Publicado: (2023) -
Effects of Tissue Pressure on Transgene Expression Characteristics via Renal Local Administration Routes from Ureter or Renal Artery in the Rat Kidney
por: Oyama, Natsuko, et al.
Publicado: (2020) -
Suppression of Peritoneal Fibrosis by Sonoporation of Hepatocyte Growth Factor Gene-Encoding Plasmid DNA in Mice
por: Nishimura, Koyo, et al.
Publicado: (2021) -
Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics
por: Mukai, Hidefumi, et al.
Publicado: (2022)